Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (92 total)
-
Créateur: The Medical Letter on Drugs and Therapeutics
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2021-07-15
Description: COVID-19 Vaccine Comparison Chart (online only) effectiveness by vaccine and by variant. -
Créateur: the mRNA-1273 Study Group
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-07-14
Description: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 and spread globally, prompting an international effort to accelerate development of a vaccine. The candidate vaccine mRNA-1273 encodes the stabilized prefusion… -
Créateur: the mRNA-1273 Study Group
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-04-06
Description: Interim results from a phase 3 trial of the Moderna mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine indicated 94% efficacy in preventing coronavirus disease 2019 (Covid-19). -
Créateur: the Oxford COVID Vaccine Trial Group
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-12-08
Description: A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19… -
Créateur: the Oxford COVID Vaccine Trial Group
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-02-19
Description: The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for emergency use by the UK regulatory authority, Medicines and Healthcare products Regulatory Agency, with a regimen of two standard doses given with an interval of 4–12 weeks. -
Créateur: the Oxford COVID-19 Vaccine Trial Group
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-03-30
Description: A new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 disease in the UK from November, 2020. We report a post-hoc analysis of the efficacy of the adenoviral vector vaccine, ChAdOx1 nCoV-19 (AZD1222), against this variant. -
Créateur: United Kingdom Department of Health (DH)
Sujet: Research
Type d'élément: Guide
Date de la dernière mise à jour: 2019-07-19
Description: This report summarizes the establishment of the Ebola Biobank, its governance, and how materials were safely transported in 2015 from West Africa to the United Kingdom for curation by Public Health England. The Biobank is a secure but accessible… -
Créateur: University of Minnesota, Center for Infectious Disease Research and Policy
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2017-01-17
Description: In the third major report from the Wellcome Trust–CIDRAP Ebola Vaccine Team B reflects on progress to date and the remaining challenges faced. -
Créateur: Varkey, J. B. and B. S. Ribner
Sujet: General
Type d'élément: Publication
Date de la dernière mise à jour: 2016-06-01
Description: Ending the West Africa Ebola virus disease (EVD) outbreak required an unprecedented international response. -
Créateur: Walsh, Edward E., Robert W. Frenck, Ann R. Falsey, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen Neuzil, Mark J. Mulligan, Ruth Bailey, Kena A. Swanson, Ping Li, Kenneth Koury, Warren Kalina, David Cooper, Camila…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-10-14
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the resulting disease, coronavirus disease 2019 (Covid-19), have spread to millions of persons worldwide. Multiple vaccine candidates are under development, but no vaccine is…